220 related articles for article (PubMed ID: 34552345)
1. PLAUR as a Potential Biomarker Associated with Immune Infiltration in Bladder Urothelial Carcinoma.
Liu M; Chen S; Zhang A; Zheng Q; Fu J
J Inflamm Res; 2021; 14():4629-4641. PubMed ID: 34552345
[TBL] [Abstract][Full Text] [Related]
2. FUT7 Promotes the Epithelial-Mesenchymal Transition and Immune Infiltration in Bladder Urothelial Carcinoma.
Liu M; Zheng Q; Chen S; Liu J; Li S
J Inflamm Res; 2021; 14():1069-1084. PubMed ID: 33790621
[TBL] [Abstract][Full Text] [Related]
3. High expression of
Lin B; Zhang T; Ye X; Yang H
Oncol Lett; 2020 Sep; 20(3):2840-2854. PubMed ID: 32782602
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of SNCA and its methylation in bladder cancer.
Wu Z; Xia C; Zhang C; Yang D; Ma K
BMC Cancer; 2022 Mar; 22(1):330. PubMed ID: 35346107
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer analysis of PLAU indicates its potential prognostic value and correlation with neutrophil infiltration in BLCA.
Shi K; Zhou J; Li M; Yan W; Zhang J; Zhang X; Jiang L
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166965. PubMed ID: 38000776
[TBL] [Abstract][Full Text] [Related]
6. PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma.
Ni W; Yi L; Dong X; Cao M; Zheng J; Wei Q; Yuan C
Sci Rep; 2023 Feb; 13(1):2051. PubMed ID: 36739300
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P
Front Immunol; 2023; 14():955949. PubMed ID: 37006317
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer.
Chen R; Jiang M; Hu B; Fu B; Sun T
Int J Gen Med; 2023; 16():707-722. PubMed ID: 36872941
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Investigation of Genes Associated with Cell Cycle Pathways for Prognosis and Immunotherapy in Bladder Urothelial Carcinoma.
Mi Y; Wang X
J Environ Pathol Toxicol Oncol; 2022; 41(3):1-12. PubMed ID: 35993952
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of the importance of PLAUR in the progression and immune microenvironment of renal clear cell carcinoma.
Wang Z; Wang K; Gao X; Liu Z; Xing Z
PLoS One; 2022; 17(6):e0269595. PubMed ID: 35675366
[TBL] [Abstract][Full Text] [Related]
11. miR-628-5p is a Potential Novel Prognosis Biomarker, Associated with Immune Infiltration in Bladder Urothelial Carcinoma.
Huang H; Xu Q; Zhang Y; Zhou Y; Ma K; Luo Y
Curr Pharm Des; 2023; 29(31):2477-2488. PubMed ID: 37916623
[TBL] [Abstract][Full Text] [Related]
12. Prognosis and immune infiltration analysis of endoplasmic reticulum stress-related genes in bladder urothelial carcinoma.
Wang Y; Zhu H; Wang X
Front Genet; 2022; 13():965100. PubMed ID: 36186448
[No Abstract] [Full Text] [Related]
13. Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma.
Zeng F; Li G; Liu X; Zhang K; Huang H; Jiang T; Zhang Y
Oncologist; 2021 Aug; 26(8):e1460-e1469. PubMed ID: 33687124
[TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
15. KDELR2 as a diagnostic and prognostic biomarker of bladder urothelial carcinoma and its correlation with immune infiltration.
Ma S; Sa L; Zhang J; Jiang K; Mi B; Shan L
Genet Mol Biol; 2023; 46(3):e20230002. PubMed ID: 37791813
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis reveals the value of the expression of chromobox family members for bladder urothelial carcinoma prognosis.
Meng X; Cao R; Liu X; Fu B; Luo L; Jiang M; Wang K; Liu Y; Zhu Q; Yang C; Zhou L
Oncol Lett; 2023 Apr; 25(4):172. PubMed ID: 36970607
[TBL] [Abstract][Full Text] [Related]
17. Identification of Hydroxysteroid Dehydrogenase Type 1 As a Potential Bladder Tumor Marker.
Albadawy A; Alqudaimi M; Cui H; Yan X; Sun J; Shi P
Iran Biomed J; 2024 Mar; 28(2&3):120-31. PubMed ID: 38850011
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of PTCD1 in Bladder Urothelial Carcinoma Predicts Poor Prognosis and Levels of Immune Infiltration.
Zhou Z; Zhou Y; Zhou X; Huang Y; Cui Y; Zhang Y
J Oncol; 2022; 2022():1146186. PubMed ID: 35799606
[TBL] [Abstract][Full Text] [Related]
19. MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder.
Zhu L; Liu X; Zhang W; Hu H; Wang Q; Xu K
BMC Cancer; 2022 May; 22(1):556. PubMed ID: 35581573
[TBL] [Abstract][Full Text] [Related]
20. Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer.
Gao L; Meng J; Zhang M; Fan S; Gao S; Wang X; Liang C
DNA Cell Biol; 2020 Jun; 39(6):1072-1089. PubMed ID: 32352838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
